Premium
Recent Progress in the Design and Application of Supramolecular Peptide Hydrogels in Cancer Therapy
Author(s) -
Cai Ying,
Zheng Chao,
Xiong Fengqin,
Ran Wei,
Zhai Yihui,
Zhu Helen H.,
Wang Hao,
Li Yaping,
Zhang Pengcheng
Publication year - 2021
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202001239
Subject(s) - self healing hydrogels , cancer therapy , nanotechnology , biocompatibility , supramolecular chemistry , peptide , self assembling peptide , prodrug , cancer , materials science , chemistry , medicine , nanofiber , pharmacology , biochemistry , crystal structure , polymer chemistry , metallurgy , crystallography
Supramolecular peptide hydrogel (SPH) is a class of biomaterials self‐assembled from peptide‐based gelators through non‐covalent interactions. Among many of its biomedical applications, the potential of SPH in cancer therapy has been vastly explored in the past decade, taking advantage of its good biocompatibility, multifunctionality, and injectability. SPHs can exert localized cancer therapy and induce systemic anticancer immunity to prevent tumor recurrence, depending on the design of SPH. This review first gives a brief introduction to SPH and then outlines the major types of peptide‐based gelators that have been developed so far. The methodologies to tune the physicochemical properties and biological activities are summarized. The recent advances of SPH in cancer therapy as carriers, prodrugs, or drugs are highlighted. Finally, the clinical translation potential and main challenges in this field are also discussed.